Results

Total Results: 74 records

Showing results for "corp".

21. Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. | PSNet
    psnet.ahrq.gov/issue/potential-medication-overdose-enfit-low-dose-tip-syringe-fda-safety-communication
    October 28, 2020 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

22. Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. | PSNet
    psnet.ahrq.gov/issue/potential-false-positive-results-antigen-tests-rapid-detection-sars-cov-2-letter-clinical
    April 08, 2020 - November 13, 2019 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

23. Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples. | PSNet
    psnet.ahrq.gov/issue/letter-health-care-providers-safe-use-surgical-staplers-and-staples
    October 20, 2021 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

24. Examples of Medical Device Misconnections. | PSNet
    psnet.ahrq.gov/issue/examples-medical-device-misconnections
    March 04, 2015 - May 30, 2012 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

25. Five Medication Safety Tips for Older Adults. | PSNet
    psnet.ahrq.gov/issue/five-medication-safety-tips-older-adults
    April 23, 2012 - February 3, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

26. Electronic data collection using MedWatchPlus portal and rational questionnaire. | PSNet
    psnet.ahrq.gov/issue/electronic-data-collection-using-medwatchplus-portal-and-rational-questionnaire
    July 03, 2013 - August 20, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

27. Important Warnings and Instructions for Heparin Sodium Injection (Baxter). | PSNet
    psnet.ahrq.gov/issue/important-warnings-and-instructions-heparin-sodium-injection-baxter
    May 24, 2015 - May 24, 2015 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

28. FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. | PSNet
    psnet.ahrq.gov/issue/fda-safety-communication-flexible-bronchoscopes-and-updated-recommendations-reprocessing
    March 11, 2015 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

29. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/40813/psn-pdf
    July 19, 2017 - How to develop an effective obstetric checklist. July 19, 2017 Fausett B, Propst A, Van Doren K, et al. How to develop an effective obstetric checklist. Am J Obstet Gynecol. 2011;205(3):165-70. doi:10.1016/j.ajog.2011.06.003. https://psnet.ahrq.gov/issue/how-develop-effective-obstetric-checklist This commentary di…

30. FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. | PSNet
    psnet.ahrq.gov/issue/fda-alerts-patients-and-health-care-professionals-epipen-auto-injector-errors-related-device
    April 07, 2019 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

31. FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. | PSNet
    psnet.ahrq.gov/issue/fda-safety-communication-caution-when-using-robotically-assisted-surgical-devices-womens
    September 01, 2021 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

32. FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). | PSNet
    psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-warns-about-prescribing-and-dispensing-errors-resulting
    August 05, 2020 - October 28, 2020 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

33. Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. | PSNet
    psnet.ahrq.gov/issue/meitheal-pharmaceuticals-inc-issues-voluntary-nationwide-recall-cisatracurium-besylate
    February 03, 2021 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

34. Bar code label requirement for human drug products and biological products. | PSNet
    psnet.ahrq.gov/issue/bar-code-label-requirement-human-drug-products-and-biological-products
    October 21, 2015 - August 11, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

35. Fentanyl transdermal system (marketed as Duragesic) information. | PSNet
    psnet.ahrq.gov/issue/safety-warnings-regarding-use-fentanyl-transdermal-skin-patches
    August 12, 2015 - October 28, 2020 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium

36. FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. | PSNet
    psnet.ahrq.gov/issue/fda-safety-communication-use-caution-implanted-pumps-intrathecal-administration-medicines
    June 20, 2018 - August 5, 2020 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

37. FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. | PSNet
    psnet.ahrq.gov/issue/fda-requires-label-warnings-prohibit-sharing-multi-dose-diabetes-pen-devices-among-patients
    March 04, 2015 - June 22, 2011 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

38. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. | PSNet
    psnet.ahrq.gov/issue/design-endoscopic-retrograde-cholangiopancreatography-ercp-duodenoscopes-may-impede-effective
    March 11, 2015 - May 30, 2012 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

39. Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico. | PSNet
    psnet.ahrq.gov/issue/roxane-laboratories-initiates-nationwide-voluntary-recall-single-manufacturing-lot
    June 22, 2011 - May 19, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection

40. Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. | PSNet
    psnet.ahrq.gov/issue/hospira-issues-voluntary-nationwide-recall-one-lot-05-bupivacaine-hydrochloride-injection-usp
    June 20, 2018 - May 30, 2012 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection